BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35511415)

  • 1. Comprehensive molecular profiling of pancreatic ductal adenocarcinoma in FNA, biopsy, and resection specimens.
    Razzano D; Bouza SJ; Hernandez PV; Wang M; Robert ME; Walther Z; Cai G
    Cancer Cytopathol; 2022 Sep; 130(9):726-734. PubMed ID: 35511415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB.
    Gan Q; Roy-Chowdhuri S; Duose DY; Stewart JM; Coronel E; Bhutani MS; Lee JH; Weston B; Ge PS; Ross WA; Maitra A
    Cancer Cytopathol; 2022 Apr; 130(4):275-283. PubMed ID: 34905283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.
    Sekita-Hatakeyama Y; Nishikawa T; Takeuchi M; Morita K; Takeda M; Hatakeyama K; Nakai T; Uchiyama T; Itami H; Fujii T; Mitoro A; Sho M; Ohbayashi C
    PLoS One; 2018; 13(3):e0193692. PubMed ID: 29494669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of endoscopic ultrasound tissue acquisition methods for genomic analysis of pancreatic cancer.
    Elhanafi S; Mahmud N; Vergara N; Kochman ML; Das KK; Ginsberg GG; Rajala M; Chandrasekhara V
    J Gastroenterol Hepatol; 2019 May; 34(5):907-913. PubMed ID: 30422342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FNA smears of pancreatic ductal adenocarcinoma are superior to formalin-fixed paraffin-embedded tissue as a source of DNA: Comparison of targeted KRAS amplification and genotyping in matched preresection and postresection samples.
    Hartley CP; Mahajan AM; Selvaggi SM; Rehrauer WM
    Cancer Cytopathol; 2017 Nov; 125(11):838-847. PubMed ID: 29024530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy.
    Trisolini E; Armellini E; Paganotti A; Veggiani C; Bozzola C; Frattini M; Pizio C; Mancuso G; Andorno S; Boldorini R
    Pathology; 2017 Jun; 49(4):379-386. PubMed ID: 28450086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic Ultrasound-Guided Fine-Needle Biopsy Versus Aspiration for Tissue Sampling Adequacy for Molecular Testing in Pancreatic Ductal Adenocarcinoma.
    Mohamed WT; Jahagirdar V; Jaber F; Ahmed MK; Fatima I; Bierman T; Fu Z; Jones PG; Hassan AF; Faber E; Clarkston WK; Ghoz H; Tawfik OW; Jonnalagadda S
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of endoscopic ultrasound-guided fine-needle biopsy versus fine-needle aspiration for genomic profiling and DNA yield in pancreatic cancer: a randomized crossover trial.
    Kandel P; Nassar A; Gomez V; Raimondo M; Woodward TA; Crook JE; Fares NS; Wallace MB
    Endoscopy; 2021 Apr; 53(4):376-382. PubMed ID: 32767288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples.
    Redegalli M; Grassini G; Magliacane G; Pecciarini L; Schiavo Lena M; Smart CE; Johnston RL; Waddell N; Maestro R; Macchini M; Orsi G; Petrone MC; Rossi G; Balzano G; Falconi M; Arcidiacono PG; Reni M; Doglioni C; Cangi MG
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2825-2833. PubMed ID: 36280101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
    Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
    Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should
    Béchade D; Palmieri LJ; Bonhomme B; Pernot S; Léna J; Fonck M; Pesqué S; Boillet G; Italiano A; Roseau G
    Therap Adv Gastroenterol; 2024; 17():17562848231224943. PubMed ID: 38250014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma.
    Park JK; Lee YJ; Lee JK; Lee KT; Choi YL; Lee KH
    Oncotarget; 2017 Jan; 8(2):3519-3527. PubMed ID: 27974679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Droplet digital polymerase chain reaction detection of KRAS mutations in pancreatic FNA samples: Technical and practical aspects for routine clinical implementation.
    Mansour Y; Boubaddi M; Odion T; Marty M; Belleannée G; Berger A; Subtil C; Laurent C; Dabernat S; Amintas S
    Cancer Cytopathol; 2024 May; 132(5):274-284. PubMed ID: 38308613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliable Detection of Somatic Mutations for Pancreatic Cancer in Endoscopic Ultrasonography-Guided Fine Needle Aspirates with Next-Generation Sequencing: Implications from a Prospective Cohort Study.
    Habib JR; Zhu Y; Yin L; Javed AA; Ding D; Tenior J; Wright M; Ali SZ; Burkhart RA; Burns W; Wolfgang CL; Shin E; Yu J; He J
    J Gastrointest Surg; 2021 Dec; 25(12):3149-3159. PubMed ID: 34244950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and diagnostic value of next-generation sequencing analysis of residual liquid-based cytology specimens of pancreatic masses.
    Sekita-Hatakeyama Y; Fujii T; Nishikawa T; Mitoro A; Sawai M; Itami H; Morita K; Uchiyama T; Takeda M; Sho M; Yoshiji H; Hatakeyama K; Ohbayashi C
    Cancer Cytopathol; 2022 Mar; 130(3):202-214. PubMed ID: 34665935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic utility of methylthioadenosine phosphorylase immunohistochemistry for pancreatic ductal adenocarcinoma in FNA and small biopsy specimens.
    Yu S; Doyle LA; Hornick JL; Mito JK
    Cancer Cytopathol; 2024 Feb; 132(2):87-95. PubMed ID: 38054349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors.
    Crinò SF; Ammendola S; Meneghetti A; Bernardoni L; Conti Bellocchi MC; Gabbrielli A; Landoni L; Paiella S; Pin F; Parisi A; Mastrosimini MG; Amodio A; Frulloni L; Facciorusso A; Larghi A; Manfrin E
    Pancreatology; 2021 Mar; 21(2):443-450. PubMed ID: 33390343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS Mutation Testing on Endoscopic Ultrasound-Guided Fine-Needle Aspiration Samples Improves the Diagnostic Accuracy of Pancreatic Cancer.
    Yeung MCF; Shek TWH
    Pancreas; 2022 Nov-Dec 01; 51(10):1365-1371. PubMed ID: 37099780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic ultrasound-guided sampling of solid pancreatic masses: 22-gauge aspiration versus 25-gauge biopsy needles.
    Yang MJ; Yim H; Hwang JC; Lee D; Kim YB; Lim SG; Kim SS; Kang JK; Yoo BM; Kim JH
    BMC Gastroenterol; 2015 Sep; 15():122. PubMed ID: 26419845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Testing in Pancreatic Cancer.
    Benesova L; Halkova T; Bunganic B; Belsanova B; Zavoral M; Traboulsi E; Minarik M
    Pathol Oncol Res; 2020 Jan; 26(1):379-385. PubMed ID: 30361898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.